Balchem Q1 net sales $250.5M record; adj. EPS $1.22 vs $1.03 YoY; all segments grow

BALCHEM CORP

2025-Q1 EPS reported $1.13 revenue$250,519,000

Net sales of $250.5M, up 4.5% YoY; GAAP EPS $1.13 vs $0.89; adjusted EPS $1.22 vs $1.03.
Record adjusted EBITDA of $66.3M, up 8.9% YoY; net earnings $37.1M, up 27.8%.
All three segments (Human Nutrition, Animal Nutrition, Specialty Products) posted sales and earnings growth.
Operating cash flow $36.5M; free cash flow $31.0M in Q1 2025.
Launched new corporate website and product brand sites; released 2024 Sustainability Report on April 22.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.